Kibdelone B is a natural product primarily explored for its potential in cancer therapy due to its potent cytotoxic properties. It has shown significant activity against various cancer cell lines, particularly colon and lung cancers, making it a promising candidate for the development of new anticancer drugs. Researchers are particularly interested in its ability to inhibit tumor growth and induce apoptosis in cancer cells. Additionally, Kibdelone B exhibits potential antibacterial activity against drug-resistant bacteria, such as MRSA. It is studied for its unique mechanism of action, which may provide insights into novel pathways for targeted cancer treatments and antimicrobial therapies. Its applications extend to biomedical research, where it serves as a tool to understand cellular processes, drug resistance mechanisms in oncology, and bacterial infections.